Mother-to-child transmission of HIV-1 afflicts hundreds of thousands of children every year, especially in parts of the world such as sub-Saharan Africa, where HIV infection is prevalent and resources are limited. This tragic reality has spurred researchers to search for an effective, safe, and inexpensive treatment that could reduce the risk of perinatal HIV transmission. The HIVNET 012 trial was designed to provide preliminary information on the comparative safety and efficacy of two relatively simple and inexpensive short courses of oral antiretroviral treatment likely to be feasible in resource-limited settings.
The resulting report identified some problems with procedures and documentation, but concluded that these issues did not compromise the results of the study. However, these issues have led to public scrutiny and continued controversy. Review of the HIVNET 012 Perinatal HIV Prevention Study critically and objectively evaluates the study's design and conduct, and assesses the impact of the initial procedural issues on the validity of the overall findings and conclusions of the trial.
Table of Contents
|2 Overview of HIVNET 012||18-26|
|3 Study Design, Treatment, Assignment, and Adherence to Study Regimens||27-47|
|4 Efficacy and Safety||48-72|
|5 Review of Ethical Issues||73-97|
|6 Response to the Charge to the Committee||98-108|
|Appendix A: Agendas of Information-Gathering Meetings||109-112|
|Appendix B: Comparisons to Other Perinatal HIV Prevention Studies Using NVP and AZT||113-129|
|Appendix C: Committee Biographies||130-136|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Review of the HIVNET 012 Perinatal HIV Prevention Study...